Artificial Intelligence (AI) is significantly transforming biological academia, exemplified by tools like ImmunoMatch, which predicts antibody assembly and enhances therapeutic design. Developed by UCL’s Fraternali Lab, ImmunoMatch accelerates drug development and personalized medicine. The integration of AI in research promises substantial advancements in immunological therapy, benefiting patient care and pharmaceutical innovation.